Plant ID: NPO18832
Plant Latin Name: Berberis thunbergii
Taxonomy Genus: Berberis
Taxonomy Family: Berberidaceae
NCBI TaxonomyDB:
121720
Plant-of-the-World-Online:
n.a.
Anthelmintic; Antibacterial; Antiseptic; Cancer; Febrifuge
China
GAA; | |
USP2; | |
SMN1;SMN2; | |
LMNA; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | USP2 | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | CHEMBL1293227 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 7.764E-04 | 8.669E-01 | CYP3A4 |
BP | GO:0008152; metabolic process | GO:0000023; maltose metabolic process | 7.764E-04 | 8.669E-01 | GAA |
BP | GO:0007610; behavior | GO:0007626; locomotory behavior | 8.385E-04 | 8.669E-01 | GAA, USP2 |
MF | GO:0003824; catalytic activity | GO:0070576; vitamin D 24-hydroxylase activity | 7.764E-04 | 8.669E-01 | CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0032450; maltose alpha-glucosidase activity | 7.764E-04 | 8.669E-01 | GAA |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 1.035E-03 | 8.669E-01 | CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0004558; alpha-1,4-glucosidase activity | 1.035E-03 | 8.669E-01 | GAA |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 2.225E-02 | 1.000E+00 | CYP3A4, GAA, LMNA |
CC | GO:0044464; cell part | GO:0005635; nuclear envelope | 4.149E-02 | 1.000E+00 | LMNA |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 7.230E-03 | 2.744E-02 | CYP3A4 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00500 | Starch and sucrose metabolism | 1.392E-02 | 2.744E-02 | GAA |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 1.145E-02 | 2.744E-02 | CYP3A4 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 7.478E-03 | 2.744E-02 | GAA |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.713E-02 | 2.744E-02 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.812E-02 | 2.744E-02 | CYP3A4 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.763E-02 | 2.744E-02 | CYP3A4 |
09160 Human Diseases | 09165 Cardiovascular diseases | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 1.837E-02 | 2.744E-02 | LMNA |
09160 Human Diseases | 09165 Cardiovascular diseases | hsa05410 | Hypertrophic cardiomyopathy (HCM) | 2.058E-02 | 2.744E-02 | LMNA |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.033E-02 | 2.744E-02 | CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|